16th International AIDS Conference


Toronto, Canada - August 13 - 18, 2006


HOW WELL DO PMTCT PROGRAMS IN INDIA FACILITATE ACCESS TO HIV CARE AND SEXUAL AND REPRODUCTIVE HEALTH (SRH) SERVICES FOR HIV-POSITIVE WOMEN?

Int Conf AIDS. 2006 Aug 13-18;16 Abstract No. ThAc0105

Sharma Mahendra V.1, Sarna A.1, Rutenberg N.2, Rau A.3, Singh L.B.4, Mudoi R.3, Oinam A.4, Pakkela V.5, Panda S.6
1 Horizons/Population Council, New Delhi, India, 2 Horizons/Population Council, Washington DC, United States, 3 Freedom Foundation, Bangalore, India, 4 Social Awareness Service Organization, Imphal, India, 5 Freedom Foundation, Hyderabad, India, 6 Consultant, Horizons/Population Council, New Delhi, India


BACKGROUND: In India, 21% of the 5.1 million HIV-infected people are women of reproductive age. The national PMTCT program has demonstrated that antenatal care is an effective entry point to HIV prevention for their children. But does the PMTCT program serve as an entry point to HIV care and SRH services for HIV-infected mothers?

METHODS: 300 randomly selected HIV-positive pregnant and postpartum women (0 – 24 months post-delivery) from about 10 PMTCT sites and 30 service providers and program managers of public sector and NGO run PMTCT programs in 3 high HIV prevalence states in India were interviewed. An interim analysis of data from 101 women is presented.

RESULTS: Respondents had a mean age of 25; one-third were primagravida while a majority reported multiple pregnancies (range: 2 – 8). 82% did not want to have another child; for the majority, their HIV-status was the main reason for this decision. When post-partum women (n=80) were asked about condom use, less than half (49%) were currently using condoms to either prevent HIV transmission or prevent pregnancy. Only half of these women stated that they received their condoms from the PMTCT program.

More than 40% of the women were aware of ARV treatment, but only 18% mentioned that their PMTCT provider informed them about it and only one-fifth were told about CD4 testing. Furthermore, only 6% of women mentioned they were currently on ART and only 1 of them mentioned that their PMTCT provider referred them to the ARV facility.

CONCLUSIONS: Interim analysis indicates that linkages between PMTCT programs and HIV care and SRH services are weak. Failure to address the SRH needs of women and to connect them to HIV care is a shortcoming of the PMTCT program. Study results will be used to strengthen linkages between PMTCT and other services vital to meeting the needs of HIV-positive women.

Acrobat ReaderDownload PDF of this abstract.

Power Point PresentationDownload Power Point Presentation.

2006-08-13
ThAc0105


Copyright © 2006 - International AIDS Society (IAS). All information and content relating to the abstracts from the 16th International AIDS Conference, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is a 501c(3) not-for-profit organization made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, GlaxoSmithKline, the National Library of Medicine, Roche / Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.